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Dopaminergic neurons are known to be vulnerable to age-related neuronal disorders due to reactive oxygen species (ROS) generated during
dopamine metabolism. However, it remains unclear what kinds of proteins are involved in the response to oxidative stress. We examined changes
in whole proteins and phosphoproteins in the human dopaminergic neuroblastoma cell line SH-SY5Y under oxidative stress induced by the
dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA). Proteins of SH-SY5Y cells at various stages of oxidative stress were separated by two-
dimensional gel electrophoresis for comparative analysis. Increase in glutathione-S-transferase pi was detected on SYPRO Ruby-stained gels by
computer-aided image analysis. Stress-induced alterations in phosphoproteins were detected by Pro-Q Diamond staining. Elongation factor 2,
lamin A/C, T-complex protein 1, and heterogeneous nuclear ribonucleoprotein H3 were identified by MALDI-TOF mass spectrometry as stress-
responsive elements.
© 2006 Elsevier B.V. All rights reserved.Keywords: Oxidative stress; SH-SY5Y cell; Phosphoproteome; 6-hydroxydopamine1. Introduction
In all living cells, reactive oxygen species (ROS) such as
superoxide radicals are inevitably generated as by-products of
electron transport in mitochondria and redox enzyme reac-
tions in the cytoplasm. Oxidative stress has been implicated
in a number of age-associated disorders, neurodegenerative
diseases, and the aging mechanism itself [1,2]. Dopaminergic
neurons are especially vulnerable to age-related disorders due
to exposure to high levels of ROS generated normally as partAbbreviations: 2-DE, two-dimensional electrophoresis; CCT, chaperonin con-
taining TCP-1; EF-2, elongation factor 2; GST, glutathione S-transferase; hnRNP,
heterogeneous nuclear ribonucleoprotein; 6-OHDA, 6-hydroxydopamine;WST-1, 4-
[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1, 3-benzene disulfonate; ROS,
reactive oxygen species; TCP-1, t-complex polypeptide 1
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doi:10.1016/j.bbamcr.2006.07.008of dopamine metabolism [3]. ROS may damage neuronal cells
through oxidative modification of intracellular proteins, such
as protein carbonylation [4], methionine sulphoxidation [5,6],
and tyrosine nitration [7], resulting in conformational
alterations and loss of activity. Therefore it is not surprising
that these neuronal cells have a protective system that is
induced by exposure to oxidative stress. However, little is
known about which proteins in dopamine neurons are
involved in the signal transduction activated by dopamine
metabolite-induced oxidative stress. Protein phosphorylation
is the most significant post-translational modification of
protein that plays important roles in stress-induced signal
transduction.
In this study,we examined overall protein alterations, including
phosphorylation, in the human neuroblastoma cell line SH-SY5Y
[8,9] under oxidative stress induced by administration of 6-
hydroxydopamine (6-OHDA), a dopaminergic neurotoxin
[10,11]. 6-OHDA is a potent toxin of catecholaminergic cells
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tion in the presence of Fe2+ and hydrogen peroxide (H2O2)
[12]. Endogenous 6-OHDA has been detected in urine
samples of patients suffering from Parkinson's disease [13],
suggesting that this compound may be involved in the
pathogenesis. According to current hypotheses, 6-OHDA is
transported into the cell by catecholamine uptake systems,
where it has two biochemically independent, but possibly
synergistic actions: 6-OHDA easily forms free radicals, and
also inhibits mitochondrial respiratory chain activity [14,15].
It has been reported that 6-OHDA and dopamine cause
generation of reactive oxygen species, activation of caspases
and c-Jun N-terminal kinase, and DNA fragmentation in
cultured neuronal cells and various neuroblastoma cell lines,
leading to apoptotic cell death [16,17]. Lee et al. provided the
evidence for upregulation of calreticulin in murine dopami-
nergic neuronal cells after treatment with 6-OHDA [18].
On the other hand, the ubiquitin–proteasome pathway is
the principal mechanism for protein catabolism and has roles
in both housekeeping and the turnover of many regulatory
proteins in cells [19]. It has also been shown to have
significant involvement in the regulation of critical cellular
processes including stress responses and abnormal protein
catabolism.
Phosphorylation is the most significant post-translational
modification of protein, and plays important roles in various
types of metabolic regulation and signal transduction. Two-
dimensional gel electrophoresis-based proteomics is the most
appropriate method for analyzing protein phosphorylation
because phosphorylated protein shows a drift in the isoelectric
point in the first-dimensional isoelectric focusing. A novel
fluorescent phosphosensor, Pro-Q Diamond Phosphoprotein
stain [20], is capable of sensitive detection of phosphorylated
forms of proteins separated by gel electrophoresis. We have
previously confirmed the specificity and sensitivity of Pro-Q
Diamond Phosphoprotein stain [21]. Stasyk et al. [22] have
used phosphospecific staining successfully for quantitative
analysis of phosphoproteins in EpH4 cells. In the present
study, we performed sequential gel staining with Pro-Q
Diamond and SYPRO Ruby, and mass spectrometric
identification to investigate the changes in protein phosphor-
ylation in SH-SY5Y cells under 6-OHDA-induced oxidative
stress.
2. Materials and methods
2.1. Materials
Immobiline DryStrips (7 cm and 18 cm), horse-radish peroxidase-
conjugated mouse IgG, and a detection kit for enhanced chemiluminescence
(ECL-plus) were purchased from Amersham Pharmacia Biotech (Piscataway,
NJ, USA). The marker proteins for IEF were obtained from Daiichi Pure
Chemicals Co. (Tokyo, Japan). Trifluoroacetic acid (TFA), dithiothreitol (DTT),
α-cyano-4-hydroxy-trans-cinnamic acid (CHCA), phosphatase inhibitor cock-
tails 1 and 2, and iodoacetamide were obtained from Sigma-Aldrich (St. Louis,
MO, USA). 2,5-Dihydroxybenzoic acid (DHB) was obtained from WAKO Pure
Chemical Industries Ltd. (Osaka, Japan). Trypsin and protease inhibitor cocktail
were purchased from ProMega (Madison, WI, USA) and Pierce Chemicals
(Rockford, IL, USA), respectively. Immobilon-P and ZipTip (μC18) wereobtained from Millipore Co. (Billerica, MA, USA). SYPRO Ruby gel stain, an
RC DC protein assay kit and a ReadyPrep Protein Extraction Kit (Cytoplasmic/
Nuclear) were purchased from Bio-Rad Laboratories (Hercules, CA, USA). Pro-
Q Diamond phosphoprotein gel stain and Hoechst 33342 were the products of
Molecular Probes (Eugene, OR, USA). Antibodies for ubiquitin and horse-
radish peroxidase-conjugated anti-rabbit IgG were purchased from MBL
(Nagoya, Japan). Cell Proliferation Reagent WST-1 and anti-glutathione-S-
transferase (GST)-pi were obtained from Roche (Basel, Switzerland) and BD
Biosciences (San Jose, CA, USA), respectively. Polyclonal antibody against
lamin A/C was the product of IMGENEX Corporation (San Diego, CA, USA),
and 5–20% polyacrylamide gradient gels for second-dimensional SDS-PAGE
were obtained from Anatech (Tokyo, Japan). Annexin V-FITC apoptosis
detection kit and FLICA apoptosis detection kit were purchased from Alexis
Biochemicals (San Diego, CA, USA) and Immunochemistry Technologies, LLC
(Bloomington, MN, USA), respectively.
2.2. Cell culture
The dopaminergic neuroblastoma cell line SH-SY5Y was obtained from the
Human Science Research Resources Bank (Osaka, Japan). The cells were
cultured in Dulbecco's minimum essential medium (Gibco) supplemented with
10% heat-inactivated fetal bovine serum, streptomycin (0.1 mg/ml), and
penicillin (100 units/ml) in a water-jacketed incubator at 37 °C in a humidified
atmosphere of 5% CO2/95% air.
2.3. Cell viability assay
Cell viability was assessed after 6-OHDA administration using 4-[3-(4-
iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1, 3-benzene disulfonate (WST-1)
cell survival assays. SH-SY5Y cells were seeded in 24-well plates at a density of
5–20×104 cells/well in 500 μl of phenol red-free medium and allowed to attach
for 24 h before treatment. After treatment of the cells with various concentrations
of 6-OHDA for up to 24 h, 50 μl/well Cell Proliferation Reagent WST-1 was
added and the cells were incubated for 1 h in a CO2 incubator at 37°C. The
absorption was determined in an Emax microplate reader (Molecular Devices) at
λ=450/650 nm after automatic subtraction of background readings. The results
are expressed as a percentage of the untreated control. For cytochemical
detection of apoptosis, we also examined using Annexin V-FITC apoptosis
detection kit and FLICA apoptosis detection kit according to the manufacturers'
instructions.
2.4. Sample preparation for 2-D electrophoresis
After treatment of the cells with 6-OHDA, the cells were washed with cold
PBS twice, and harvested by scraping. The cell pellets were suspended in lysis
buffer containing 5 M urea, 2 M thiourea, 2% (w/v) 3-[(3-cholamidopropyl)
dimethylammonio]-1-propanesulfonate (CHAPS), 2% (w/v) sulfobetaine 10,
2% Pharmalyte 3–10, 65 mM dithiothreitol (DTT), protease and phosphatase
inhibitor cocktails. The cell suspensions were sonicated intermittently,
centrifuged, and the supernatant fractions were collected. In some experiments,
highly enriched fractions of cytoplasmic and nuclear proteins were prepared
from the cell pellets using the ReadyPrep protein extraction kit (cytoplasmic/
nuclear). The protein concentration for each sample was determined by RC DC
Protein assay, which is both reducing agent-compatible and detergent-
compatible, according to the manufacturer's instructions using BSA as a
standard.
2.5. High-resolution 2-D gel electrophoresis
2-D electrophoresis was performed using the IPG–DALT system [23]
according to our standard procedure described previously [24]. The first-
dimensional isoelectric focusing (IEF) was carried out on nonlinear immobilized
pH gradients (Immobiline DryStrip; pH 3–10; 18 cm long and 7 cm long;
Amersham Biosciences, Uppsala, Sweden). Passive sample application during
rehydration was performed by placing the Immobiline DryStrip gel side down
overnight in a rehydration tray that contained the sample in the rehydration
solution (6 M urea, 2 M thiourea, 1% Pharmalyte 3–10, 13 mM DTT, 2.5 mM
Fig. 2. Increase in ubiquitin-conjugated proteins of SH-SY5Y cells under 6-
OHDA-inducedoxidativestress.SH-SY5Ycellswereexposed to50μM6-OHDA
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proteins in the sample are absorbed and distributed over the entire length of the
strip. The IEF (for 18-cm-long IPG) was performed at 20 °C using a
PowerPhoreStar Pro 3800 (Anatech, Tokyo, Japan) on the following voltage
program: 500 V for 2 h, 700 V for 1 h, 1000 V for 1 h, 1500 V for 1 h, 2000 V for
1 h, 2500 V for 1 h, 3000 V for 1 h, 3500 V for 18 h. After electrofocusing, the
IPG strips were equilibrated for 30 min in buffer containing 6 M urea, 25% (v/v)
glycerol, 2% (w/v) SDS, 0.025 M Tris–HCl, pH 6.8, 0.5% (w/v) DTT and then
alkylated for 20 min in buffer containing 0.3 M iodoacetamide, 30% (v/v)
glycerol, 2.5% (w/v) SDS, 0.03 M Tris–HCl, pH 6.8. In the second-dimensional
SDS-PAGE, equilibrated IPG strips were placed on top of the 7.5%
polyacrylamide gels (18 cm×20 cm×1 mm) and run with SDS running buffer
(0.1 M Tris, 0.1 M Tricine, 0.1% SDS) at a constant current of 20 mA/gel until
the dye front reached the bottom of the gel. In the case of 2-DE performed using
7-cm-long IPG, the voltage programs for IEF and 2-D gels were replaced as
follows: 500 V for 1.5 h, 700 V for 15 min, 1000 V for 15 min, 1500 V for
15 min, 2000 V for 15 min, 2500 V for 15 min, 3000 V for 15 min, 3500 V for
4 h; 10% polyacrylamide gels (8 cm×6.5 cm×1 mm) or 5–20% gradient Tris–
glycine precast gels. The gel was fixed and the proteins were detected by
staining with SYPRO Ruby Protein Gel Stain (Bio-Rad). The stained gels were
scanned using a Molecular Imager FX laser scanning fluorometer (Bio-Rad,
Richmond, USA) and analyzed using PDQuest software (Bio-Rad, Richmond,
USA). pI/Mr calibration of all protein spots was carried out by co-migration with
2D-protein pI and MWmarker (Daiichi Pure Chemicals Co. Ltd.) as the internal
standard landmarks. The 2-D gels were stained with Pro-Q Diamond for
detecting phosphoproteins first, and the fluorescent spot images were acquired
using a Molecular Imager FX (Bio-Rad) with a 532-nm laser for excitation and a
555-nm long-pass filter for emission. The gels were further stained with
SYPRO-Ruby for scanning the entire protein spots with a 488-nm laser and a
640-nm band-pass filter. The procedure used for the sequential gel staining isFig. 1. Effect of 6-OHDA on viability of SH-SY5Y cells. The cells were
incubated with various concentrations of 6-OHDA for 24 h (A), or with 50 μM
6-OHDA for different time periods (B). Cell viability was assessed by theWST-1
method and expressed as a percentage relative to untreated controls. Data from
three independent cultures in triplicate were expressed as the mean±SD.
for different incubation periods (a), or to various concentrations of 6-OHDA for
24 h (b). Proteins in cell lysates were subjected to 7.5%TSDS-PAGE followed by
Western blot analysis using anti-ubiquitin antibody. (A) Whole protein pattern
visualized by staining with SYPRO Ruby. (B) Ubiquitin-conjugated proteins
visualized byWestern blotting with anti-ubiquitin antibody.described in our web site (http://proteome.tmig.or.jp/2D/2D-method.html) in
detail.
2.6. Identification of protein
For mass spectrometric identification, protein spots on the SYPRO Ruby-
stained 2-DE gel were excised using a FluoroPhoreStar 3000 (Anatech Co.)
or ProteomeWorks Spot Cutter (Bio-Rad). In some experiments, Pro-Q
Diamond-stained phosphoproteins were cut out directly with a FluoroPhor-
eStar 3000. In-gel digestion was performed according to our standard protocol
shown in our website with slight modifications. The gel pieces were
dehydrated in 50% acetonitrile and 50% ammonium bicarbonate, then in
100% acetonitrile, and finally dried. The proteins were digested with 5 μg/ml
trypsin overnight at 30°C in 30% acetonitrile and 50 mM ammonium
bicarbonate. After digestion, peptide fragments extracted in the trypsin
solution were subjected to MALDI-TOF MS (mass spectrometry) (AXIMA-
CFR; Shimadzu, Kyoto, Japan) for peptide mass fingerprinting (PMF). In
some cases the supernatants were pooled and concentrated in a Savant AES
1010 Automatic Environmental SpeedVac system. The sample was solubi-
lized in 0.1% TFA, then adsorbed onto reverse-phase Zip-Tip μC18
(Millipore Corp.). The resin was washed with 0.1% TFA and the peptides
were eluted with 50% acetonitrile in 0.1% TFA. The eluate was analyzed by
MALDI-TOF MS using CHCA as a matrix in reflectron positive ion mode.
The background noise was removed by subtraction of mass signals obtained
from a control gel. Protein identification was carried out primarily using the
PMF Search of Mascot (http://www.matrixscience.com/; Matrix Science Ltd.)
and the MS-Fit search engine in Protein Prospector (http://prospector.ucsf.edu/;
UCSF Mass Spectrometry Facility) by sending a query of the PMF peak list.
In order to confirm the identification, samples were further analyzed by
MALDI-QIT-TOF MS/MS (AXIMA-QIT; Shimadzu, Kyoto, Japan) using
DHB as a matrix in positive ion quadrupole ion-trap (QIT) collision-induced
980 M. Nakamura et al. / Biochimica et Biophysica Acta 1763 (2006) 977–989dissociation (CID) mode. A MS/MS ion search of Mascot was used for the
confirmation.
2.7. Western blotting
For 1-D western blotting analysis, the cells were lysed in Laemmli sample
buffer and boiled. The protein concentration in the cell lysates was determined
using an RC DC Protein assay kit and an equal amount of protein for each
sample was separated by SDS-PAGE on 7.5% and 10% gels. Electrical
transfer onto a polyvinylidene difluoride (PVDF) membrane was carried out
with a semi-dry electroblotting apparatus at ca. 1 mA/cm2 for 2 h at room
temperature using a buffer containing 25 mM Tris, 192 mM glycine, 0.1%Fig. 3. 2-DE analysis of protein alterations in SH-SY5Y cells under oxidative stress.
control stress-free conditions (A). Histogram showing the relative abundance of prote
is inserted on the left side. The SYPRO Ruby-stained gels were scanned using a M
software. Normalization was done automatically using the local regression model,
Relative abundance of each spot was expressed as a percentage relative to untrea
mean±SD and compared using unpaired two-tailed t-test. * indicates P<0.05 whe
spot No. 17 was done by Western blotting (B). The SH-SY5Y cells were exposed t
were separated by 2-DE. For Western blot analysis, whole protein spots on the 2-D g
PVDF membrane using a semi-dry blotting apparatus in a Tris-glycine buffer system
image of protein spots on the PVDF membranes was acquired with the Imager aga
subjected to immunochemical detection with anti-GST-pi antibody. Panel b represen
SH-SY5Y cells under non-stress conditions; panel c, 50 μM 6-OHDA-treated SHSDS and 20% methanol. The membranes were treated with 5% skim milk in
Tris-buffered saline with Tween-20 (TBS-T; 20 mM Tris–HCl, pH 7.6,
137 mM NaCl, 0.05% Tween-20) for blocking nonspecific binding, and
incubated sequentially with a primary antibody and with horse-radish
peroxidase-conjugated secondary antibodies, followed by ECL detection. For
Western blotting of 2-DE gels, the SYPRO Ruby-stained gel was incubated in
resolubilization buffer (0.2% w/v SDS, 0.3% w/v Tris, 0.7% w/v glycine) for
15 min, and proteins were transferred onto a PVDF membrane using a semi-
dry electroblotting apparatus. Electrotransfer was carried out as described
above and the fluorescence image on the PVDF membrane was acquired using
a Molecular Imager FX laser scanning fluorometer. The PVDF membranes
were further subjected to immunoblotting with a primary antibody and a
secondary antibody.The 2-DE gel image presents a typical protein profile for SH-SY5Y cells under
in spot No. 17 in the cells after treatment with various concentrations of 6-OHDA
olecular Imager FX laser scanning fluorometer and analyzed using PDQuest
which is the most sophisticated normalization method available in PDQuest.
ted controls. Data from three independent experiments were expressed as the
n compared to untreated control. Confirmation of the identification of protein
o various concentrations of 6-OHDA for 24 h, and proteins in the cell extracts
els were stained with SYPRO Ruby, re-solubilized, and electro-transferred to a
(25 mM Tris, 192 mM glycine, 0.1% SDS, 20% methanol). The fluorescence
in (a), and the local areas on the membranes around spot No. 17 were further
ts the immunoreactive GST-pi spot in the same area as panel a. Panels a and b,
-SY5Y cells.
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3.1. Effect of 6-hydroxydopamine on viability of SH-SY5Y cells
After exposure to various concentrations of 6-OHDA for
24 h, cell viability was determined by WST-1 assay. As shown
in Fig. 1A, SH-SY5Y cells were resistant to 6-OHDA at
concentrations lower than 25 μM. At concentrations higher than
50 μM, 6-OHDA reduced cell viability significantly after 24 h
of treatment. Treatment of SH-SY5Y cells with 100 μM 6-
OHDA resulted in morphological changes typical of apoptosis,
including cell rounding and detachment from the plate, as
observed by phase contrast microscopy (data not shown). We
also examined oxidative stress-related apoptotic changes using
Annexin V-FITC apoptosis detection kit and FLICA apoptosis
detection kit based on poly-caspases assay. Microscopic
observation revealed that attached cells showed no significant
changes after exposure to 0–50 μM of 6-OHDA while loosely
attached cells were positive to these reagents (data not shown).
Therefore, all subsequent proteomic analyses were performed
using cells treated with up to 50 μM 6-OHDA. Fig. 1B shows
the time course of the effects of 50 μM 6-OHDA on cell
viability. Cytotoxic effects of 6-OHDA on SH-SY5Y cells were
time-dependent, and a significant reduction of cell viability was
evident after 8 h of incubation.
3.2. 6-OHDA-induced accumulation of ubiquitin-conjugated
proteins in SH-SY5Y cells
To examine the effect of 6-OHDA on ubiquitin conjuga-
tion, 6-OHDA-treated cells were solubilized with SDS-sampleTable 1
Summary of proteins identified in the survey of oxidative stress-responsive element
Spot no. Protein name Accession no.
1 elongation factor 2 P13639
2 elongation factor 2 P13639
3 elongation factor 2 P13639
4 elongation factor 2 P13639
5 elongation factor 2 P13639
6 heat shock cognate 71 kDa protein P11142
7 heat shock cognate 71 kDa protein P11142
8 stress-70 protein (GRP 75) P38646
9 T-complex protein 1 α subunit (TCP-1-α) P17987
10 dihydropyrimidinase related protein-2 (DRP-2) Q16555
11 T-complex protein 1 γ subunit (TCP-1-γ) P49368
12 T-complex protein 1 γ subunit (TCP-1-γ) P49368




15 heterogeneous nuclear ribonucleoprotein H3 P31942
16 heterogeneous nuclear ribonucleoprotein H3 P31942
17 glutathione-S-transferase pi (GST-pi) P09211
18 T-complex protein 1 ζ subunit (TCP-1-ζ) P40227
19 Lamin A/C P02545
20 Lamin A/C P02545
a A variant form in Swiss-Prot Protein Database.buffer and subjected to SDS-PAGE followed by Western
blotting using anti-ubiquitin antibody. As shown clearly in
Fig. 2, time-dependent and dose-related increases in ubiquitin-
conjugated proteins of SH-SY5Y cells occurred under
oxidative stress, suggesting an accumulation of abnormal
proteins.
3.3. 6-OHDA-induced proteome alteration in SH-SY5Y cells
Fig. 3A shows a typical 2-D gel protein map of control SH-
SY5Y cells detected by SYPRO Ruby-staining. We identified
several spots of interest by MALDI-TOF MS based on PMF
(spots Nos. 1–17). Table 1 summarizes the proteins identified
and their accession numbers, molecular weights, pI, and
MOWSE scores. Identification of phosphorylated proteins is
discussed in more detail in Section 3.5.
Quantitative comparison was performed using PDQuest
software to assess the relative abundance of altered proteins
on 2-D gel maps of the cells after treatment with different
concentrations of 6-OHDA. The vast majority of these
protein spots did not show significant alterations in relative
abundance under oxidative stress, but changes were evident
for several spots including spot number 17 (Fig. 3A). Spot
number 17 showed a dose-dependent increase under the
effect of 6-OHDA treatment (Fig. 3A). This spot was
identified presumptively as GST-pi by a PMF Mascot
search (Table 1) and confirmed by Western blotting with
anti-GST-pi antibody (Fig. 3B). The increase in GST-pi
after treatment with 6-OHDA was also detected by single-
dimensional Western blotting of whole-cell extracts (data
not shown).s in SH-SY5Y cells induced with 6-OH-OHDA
Mowse scores Theoretical values Pro-Q Diamond
staining
MS-Fit Mascot Mass pI
5.148.E+05 93 95339 6.4 Positive
7.129.E+05 90 95339 6.4 Negative
3.638.E+06 96 95339 6.4 Weak
2.516.E+06 91 95339 6.4 Negative
8.079.E+05 89 95339 6.4 Negative
1.148.E+06 143 70899 5.4 Negative
1.370.E+04 60 70899 5.4 Positive
9.757.E+05 75 73681 5.9 Negative
1.125.E+05 73 60344 5.8 Positive
5.789.E+05 118 62294 6.0 Negative
5.137.E+06 92 60403 6.1 Positive
5.137.E+06 92 60403 6.1 Negative
3.842.E+07 147 58025 6.2 Negative
2.896.E+04 55 54151 7.6 Negative
5.624.E+05 62 36927 6.4 Positive
6.828.E+04 93 36927 6.4 Negative
33 23438 5.44 Negative
52 58025 6.2 Positive
105 65141 6.4 Positive
1.594.E+09 85 74140 6.6 a
74 65150 6.54 Negative
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after exposure to 6-OHDA
Fig. 4 shows the effect of 6-OHDA treatment on the Pro-Q
Diamond-stained phosphoproteome profiles of SH-SY5Y cells.
Comparative analysis of phosphorylated proteins performed
using PDQuest software revealed that several protein spots
varied in phosphorylation level depending on the degree of
oxidative stress (Figs. 4 and 5). The relative abundance of spot
No. 1, corresponding to a 95-kDa/pI 6.7 phosphoprotein,
declined in the presence of 25 μM 6-OHDA (Fig. 5A), at which
concentration more than 90% of the cells were still viable (Fig.
1A). Spot No. 19, corresponding to a 66-kDa/pI 6.6 phos-
phoprotein, tended to increase even in the presence of 10 μM 6-
OHDA (Fig. 5A), at which concentration all the cells were
resistant to a low level of oxidative stress (Fig. 1A). The
increases in the phosphorylation level of spot No. 19 andFig. 4. 2-DE phosphoprotein profiles of SH-SY5Y cells. (A and B) SH-SY5Y cells w
d, 50 μM) for 24 h. Cell lysates were subjected to 2-D gel electrophoresis under two
DryStrip; SDS-PAGE on 7.5% polyacrylamide gel, Tris–Tricine buffer system, in pan
polyacrylamide gel, Tris–glycine buffer system). Panel C: time course of effect of 50
(b), or 24 h (c) and harvested. Cell lysates were subjected to 2-D gel electrophoresi
Diamond phosphoprotein gel stain. Close-ups of the areas around spots Nos. 1 anddecreases in spot No. 1 were also detected using a separate 2-D
gel system (7 cm IPG, pH 3–10, 10% gel, Tris–glycine system),
as shown in Fig. 4B. Fig. 4C summarizes the time course of the
effect of 50 μM 6-OHDA on the phosphorylation level of these
proteins. These 2-D gel-based phosphoproteome profiles
suggested that the changes in phosphorylation level of spots
Nos. 19 and 1 were time-dependent, consistent with the dose-
related changes.
3.5. Identification of phosphoproteins showing
6-OHDA-induced alterations on Pro-Q Diamond-stained
2-D gels
In our preliminary study [21], we had confirmed the high
specificity and sensitivity of Pro-Q Diamond to phosphorylated
proteins by complete dephosphorylation using hydrofluoric
acid according to the method of Kuyama et al. [25].ere exposed to various concentrations of 6-OHDA (a, 0 μM; b, 10 μM; c, 25 μM;
different conditions (in panel A: IEF on 18-cm long, pH 3–10 NL Immobiline
el B: IEF on 7-cm long, pH 3–10 NL Immobiline DryStrip; SDS-PAGE on 10%
μM 6-OHDA. SH-SY5Y cells were exposed to 50 μM 6-OHDA for 1 h (a), 4 h
s in the large gel system as described above. 2-D gels were stained with Pro-Q
19 are shown in panel C.
Fig. 5. Changes in protein phosphorylation in SH-SY5Y cells under 6-OHDA- induced oxidative stress. (A) The Pro-Q Diamond-stained phosphoprotein profile of
SH-SY5Y cells under non-stress conditions and histograms of spot intensities whose levels changed under 6-OHDA-induced oxidative stress. 2-DE gels were stained
with Pro-Q Diamond phosphoprotein gel stain followed by staining with SYPRO Ruby gel stain to detect the relative phosphorylation level of the protein in each spot.
After staining with each dye, the gel images were acquired with a Molecular Imager FX laser scanning fluorometer (Bio-Rad). In the areas shown in close-up (B and
C), phosphorylation of protein spot No. 1 (B) and protein spots Nos. 15, 18, and 19 (C) was revealed by merging the Pro-Q Diamond-stained gel image with the
corresponding SYPRO-Ruby-stained gel image on a multi-channel viewer equipped with PDQuest software. a: Pro-Q Diamond-stained image, b: SYPRO Ruby-
stained image, c: merged image. Data reported here represent at least three independent cultures and multiple of gels. Relative fluorescence intensity was expressed as
the mean±SD and compared using unpaired two-tailed t-test. * indicates P<0.05, ** signifies P<0.01 when compared to untreated control.
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phosphoproteins in SH-SY5Y cells. Fig. 5B shows a close-up
displayed on the multi-channel viewer of PDQuest after
sequential Pro-Q Diamond and SYPRO Ruby staining of
those areas containing protein spot No. 1. Phosphoproteins
appear as green spots in the pseudo-color imaging (a) and non-
phosphorylated proteins appear as red spots (b). Protein spots
detected with both Pro-Q Diamond and SYPRO Ruby appear
orange. Proteome mapping with SYPRO Ruby indicated that
the protein, elongation factor 2, existed in at least five isoforms(Fig. 3A, spot No. 1–5, and Fig. 5B). Two of these isoforms had
already been detected by Pro-Q Diamond staining, suggesting
that we might have been detecting phosphorylated isoforms.
These spots were excised, digested with trypsin, and subjected
to MALDI-TOF mass spectrometry. As shown in Fig. 5B and C,
heavily phosphorylated proteins were not necessarily those
found in high abundance, since some of these were barely
detectable by high-sensitivity SYPRO Ruby staining. To
overcome these difficulties, several attempts were made, but
these were not completely successful. Concentration of cell
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electrolyzer (Proteome Systems) caused precipitation of target
proteins and lower resolution in two-dimensional gel electro-
phoresis. Ultimately, Pro-Q Diamond-stained phosphoproteins
were directly cut out using FluoroPhoreStar 3000 (Anatech)
before SYPRO Ruby staining for better cutting accuracy. After
tryptic digestion, the peptides extracted from the gels were
pooled, concentrated on a Zip-Tip packed with C18 reverse-
phase resin according to the manufacturer's instructions, and
subjected to MALDI-TOF mass spectrometry. Representative
mass spectra of peptides in spots Nos. 1–5 (Fig. 3) are shown in
Fig. 6. The MS peak lists obtained from the spectra were used to
search for the corresponding protein on the Swiss-Prot protein
database with the Protein Prospector search engine MS-Fit. The
protein in all these spots was identified as elongation factor 2.
The identification was confirmed by a secondary PMF search
performed using the Mascot search engine. Protein identifica-
tion was further confirmed by a MS/MS ion search of three
tryptic peptides at m/z 1091, 1544, and 1800 (Fig. 7), which
were observed in all MS spectra of spots Nos. 1–5 in Fig. 6.
These peptides were assigned to VNFTVDQIR (peptide
position, 1–9), ARPFPDGLAEDIDK (605–618), and AYLPV-
NESFGFTADLR (785–800) of elongation factor 2 by a MS/
MS ion search with a Mascot Mowse score of 74. The m/z
613.9, 1791.4, and 2704.5 peptide ions were observed only
in the MS spectrum of spot No. 1. A search in the MSFig. 6. MALDI-TOF MS spectra of tryptic peptides obtained from the spots excised
products by trypsin with m/z 2211.database using MS-Fit suggested that these peptides could be
phosphorylated.
Fig. 5C shows a zoom-up area containing protein spots Nos.
18, 15, and 19 revealed by differential imaging on the multi-
channel viewer of PDQuest after sequential staining with Pro-Q
Diamond and SYPRO Ruby. Phosphoprotein spot No. 19 was
faint in control cells but increased markedly after exposure to 6-
OHDA. Fig. 8 shows the MS (A) and MS/MS (B and C) spectra
of the tryptic digests of this protein. The phosphorylated protein
was identified as lamin A/C by PMF. The protein identification
was confirmed by MS/MS analyses of the parent ions at m/z
1605.81 and 1619.83. The monoisotopic ion at m/z 1605.81
was assigned to the peptide VAVEEVDEEGKFVR (location
440–453) of lamin A/C. The MS/MS signal of the precursor ion
at m/z 1619.83 suggested that the peptide consists of two
methylated forms of the m/z=1605.81 peptide on which
Glu444 is a site more susceptible to methylation than Glu447.
The MS spectra indicated that almost half of the phosphorylated
lamin A/C at spot 19 was methylated (Fig. 8A). To verify the
nuclear localization of phosphoprotein spot No. 19, we
performed subcellular fractionation of the protein sample before
proteome analysis. Fig. 9 clearly shows that phosphoprotein
spot No. 19 is localized mainly in the nuclear fraction (panels c
and d). Identification of spot No. 19 was further confirmed by
Western blotting with anti-lamin A/C antibody (Fig. 9e and f).
Pro-Q Diamond-negative protein spot No. 20 was alsofrom the 2-D gel shown in Fig. 3 (spots Nos. 1–5). Asterisks represent autolysis
Fig. 7. Peptide sequence analysis by MALDI-QIT-TOF MS/MS for confirmation of identification. The parent ions at m/z 1091 (A), 1544 (B), and 1800 (C) in Fig. 6
were subjected to sequence analyses by collision-induced MALDI-QIT-TOF MS/MS using AXIMA-QIT (Shimadzu). The sequences of peptides at m/z 1091 (A),
1544 (B), and 1800 (C) were assigned to VNFTVDQIR, ARPFPDGLAEDIDK and AYLPVNESFGFTADLR in EF-2, respectively.
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Fig. 8. MALDI-TOF MS spectrum of tryptic digests of phosphoprotein spot No. 19 and MS/MS spectra of precursor ions at m/z 1605.81 and 1619.83. (A) MALDI-
TOF MS spectrum. (B) MALDI-QIT-TOF MS/MS spectra of precursor ion at m/z 1605.81. (C) MALDI-QIT-TOF MS/MS spectra of precursor ion at m/z 1619.83.
Both of the precursor ions at m/z 1605.81 and 1619.83 were assigned to the same peptide sequence, VAVEEVDEEGKFVR, whereas the specific sites of glutamic acid
(Glu444 and Glu447) were methylated in the peptide ion at m/z 1619.83 only.
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Fig. 9. Localization of phosphoprotein spot No. 19 within the cell nucleus. SH-
SY5Y cells were exposed to 50 μM 6-OHDA for 24 h and harvested (a, c, and e,
control; b, d, and f, 50 μM 6-OHDA-treated). Cytoplasmic protein fractions (a
and b) and nuclear protein fractions (c, d, e, and f) were isolated from the cell
pellets using a ReadyPrep protein extraction kit (cytoplasmic/nuclear). Each
fraction was subjected to 2-D gel electrophoresis. In the horizontal dimension,
proteins were focused on a non-linear immobilized pH gradient gel strip (pH 3–
10, 7 cm long). In the vertical dimension, the proteins were further separated on
a precast gradient gel (5–20%T polyacrylamide) using a Tris–glycine buffer
system. Phosphoprotein spots were fixed on the 2-D gels and stained with Pro-Q
Diamond phosphoprotein gel stain (a, b, c, and d). For the Western blot analysis,
whole protein spots on the 2-D gels were electro-transferred to a PVDF
membrane after SYPRO Ruby staining as described in Section 2. The
immunoreactive lamin A/C spots on the PVDF membranes were detected
with an anti-lamin A/C antibody. Panels e and f represent the immunoreactive
lamin A/C spots in the same area as panels c and d, respectively.
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protein spot No. 20 confirmed the identification of lamin A/C
(Table 1). Western blot analysis also revealed that 6-OHDA-
induced oxidative stress brought about a shift from the
unphosphorylated form (spot No. 20) to the phosphorylated
form of lamin A/C (spot No. 19) (Fig. 9e and f).
Spots Nos. 15 and 16 (Figs. 3A and 5A) were identified as
heterogeneous nuclear ribonucleoprotein H3 (hnRNP H3).
Although the amount of the phosphorylated protein (Fig. 5A,
spot No. 15) was too low for further examination, spot No. 16,
the unphosphorylated form with high intensity on SYPRO
Ruby staining, was subjected to subsequent MS/MS analysis on
AXIMA-QIT. The MS/MS analyses of the parent ions at m/z
1271.69, 1428.66, and 1919.01 confirmed the identification of
hnRNP H3. These peptides were assigned to STGEAFVQ-
FASK (peptide positions 56–67), DGMDNQGGYGSVGR
(288–301) with an oxidized methionine, and ATENDIAN-
FFSPLNPIR (206–222) of hnRNP H3 by MS/MS ion search
with a Mascot score of 181. The protein of spot No. 18 was
identified as T-complex protein-1 ζ subunit (TCP-1-ζ) (Table 1).
4. Discussion
Oxidative stress due to ROS and reactive nitrogen species
(RNS) is the most plausible mechanism for age-related
deterioration of neuronal cell functions and apoptosis in
neurodegenerative disorders. While neuronal cells have adap-
tive defense mechanisms to prevent critical cell damage uponexposure to oxidative radical species, excessive levels of
oxidative stress may overwhelm these defenses and cause
apoptosis and neuronal cell loss.
In this study, we detected up-regulation of glutathione S-
transferase (GST-pi) in the human dopaminergic neuronal cell
line SH-SY5Y after treatment with 6-OHDA. Glutathione-
associated metabolism is a major mechanism of cellular
protection against agents that generate oxidative stress
[26,27], and GST protects against cell injury associated with
oxidative stress. Ishisaki et al. [28] reported up-regulation of
GST-pi mRNA with elevated levels of dopamine biosynthesis,
suggesting that GST-pi is a dopamine-inducible suppressor of
dopamine-induced apoptosis in PC12 cells. Recent research has
suggested that GST-pi may act as a NO protein carrier in cases
of cellular glutathione depletion, such as that resulting from
severe oxidative stress [29,30].
Lee et al. reported that the treatment of murine dopaminergic
neuronal cells, MN9D, with 100 μM 6-OHDA resulted in the
upregulation of calreticulin [18]. However the exposure of
human SH-SY5Y cells to 100 μM 6-OHDA caused morpho-
logical changes typical of apoptosis such as cell rounding and
detachment from the plate in our study as described in Section
3.1. In this study, we did not intend to apply so severe damage
as to induce apoptosis but to induce cellular response for
protecting against cell injury under oxidative stress. There are
several reports indicating that LD50s of 6-OHDA for SH-SY5Y
cells are 25–70 μM [11,31,32]. Our result was quite similar to
them. 6-OHDA toxicity in intact animals [33] seems to be
different compared to 6-OHDA in SH-SY5Y cells, suggesting
that specific uptake, e.g., via a neurotransmitter transporter is
missing in this cell line. Thus, the relevance for Parkinson's
disease is limited.
Protein phosphorylation and dephosphorylation are known
to be involved in the regulation of numerous cellular functions.
Dysregulation of these processes may be associated with a
number of diseases, including cancer [34] and Alzheimer's
disease [35]. Zambrano et al. [36] showed that neuronal
oxidative stress induced by H2O2 resulted in a decrease of
microtubule-associated protein τ phosphorylation.
In the present study, we found that the phosphorylation
states of EF2, lamin A/C, hnRNP, and TCP-1 were altered in
SH-SY5Y cells by treatment with 6-OHDA. In mammalian
cells, eukaryotic EF2 catalyses the translocation of peptidyl-
tRNA from the A-site to the P-site on the ribosome. EF2 is
phosphorylated by Ca2+/calmodulin-dependent kinase, known
as EF2 kinase. EF2 phosphorylation prevents binding of this
factor to the ribosome, thus inhibiting translation at the
elongation step [37]. Recently, Garcia et al. [38] reported that
EF2 was dephosphorylated significantly after transient
cerebral ischemia in rats with or without ischemic tolerance,
and in H2O2-treated NGF-differentiated PC12 cells, although
the correlation between EF2 phosphorylation status and
protein synthesis rates remains obscure. The nuclear lamins
A, B, and C are components of the nuclear lamina. Georgatos
et al. [39] found that all three lamins are substrates for protein
kinase A and that their site-specificity is controlled by
phosphorylation. However, an increase in the phosphorylation
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previously.
Heterogeneous nuclear ribonucleoprotein (hnRNP) is
known to be involved in the splicing process and participates
in early heat shock-induced splicing arrest. Stone and Collins
[40] observed rapid phosphorylation of hnRNP-C1/C2 in
response to low concentrations of H2O2 in human endo-
thelial cells. Similarly, H2O2-stimulated phosphorylation of
hnRNP-C by protein kinase CK1α modulates their RNA
binding activity [41]. The observed increase in the phos-
phorylated form of hnRNP H3 in SH-SY5Y after stimulation
with 6-OHDA in the present study may also be a protective
cellular response.
In conclusion, our investigation of differential phosphory-
lation of proteins following oxidative stress with 6-OHDA has
identified a wide range of changes in the phosphorylation/
dephosphorylation balance in various protein systems.
Furthermore, some of the above phosphoproteins, whose
phosphorylation status is altered by treatment with 6-OHDA at
concentrations lower than 25 μM, when most of the cells are
still viable, may be involved in oxidative stress-induced signal
transduction. We hypothesize that some of these processes
may, in fact, be part of the adaptive stress response that
protects neuronal cells from oxidative stress.
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